Tag Archives: bioreference

OPKO Health’s BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access

Scarlet brings diagnostic service to patients’ homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ELMWOOD PARK, N.J., January 13, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet Health™, an in-home, fully integrated digital platform providing access to on-demand diagnostic […]

Seahawks COVID-19 Testers Chosen As Honorary 12 Flag Raisers For Wild Card Weekend

Seahawks The “Seahawks Swab Team” is a big reason why the 2020 season was even possible, and they’re being honored for their extremely dedicated work testing players and staff day in and day out at the VMAC. All season long, the honor of raising the 12 Flag has gone to people and organizations who have […]

Cervical Cancer Awareness Month

January is Cervical Cancer Awareness Month and a reminder that the most important thing you can do to prevent cervical cancer is to start screening at the age of 21.  The American Cancer Society estimated that about 13,800 new cases of invasive cervical cancer would be diagnosed and about 4,290 women would die in the […]

OPKO Health’s BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide

Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47% ELMWOOD PARK, N.J., (January 4, 2021) – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of […]

Buffalo Bills and OPKO Health’s BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program

The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., December 31, 2020 – Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at […]

Apple Health

We are excited to announce that BioReference Laboratories now supports test results through Health Records on iPhone in the Apple Health app.* The Health Records feature makes it easy to see a central view of your health records from multiple providers whenever you choose, including your lab results. Getting your BioReference test results into your […]

OPKO Health’s BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test

New offering identifies COVID-19 and Influenza infections with a single sample ELMWOOD PARK, N.J., October 20, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the […]

OPKO Health’s BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools

Through New York City, BioReference will be testing students, teachers and staff in nearly 1,000 NYC public schools ELMWOOD PARK, N.J., October 9, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the beginning of its COVID-19 testing program for New York City schools throughout the 2020-2021 school year to help ensure a safer school […]

Get Educated and Get Screened During Prostate Cancer Awareness

September is Prostate Cancer Awareness Month, a time to raise awareness about the risks of prostate cancer and encourage men to take control of their prostate health by getting their regular screenings. Prostate cancer is one of the most common cancers found in American men, second only to skin cancer. In 2020, the American Cancer […]

OPKO Health’s BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]